(JTA) — NOVEMBER 31, 2020 — As the American drug company Moderna announced Monday that it had developed a COVID-19 vaccine that is 94.5% effective, Israeli scientist Tal Zaks was among the company leaders touting the good news to the media.
That’s because Zaks, who earned a doctorate at Ben-Gurion University in Beersheba, is the chief medical officer at Moderna and has been involved in overseeing its unprecedentedly rapid push for a coronavirus vaccine.
“The overall effectiveness has been remarkable … it’s a great day,” he told BBC News.
In an interview last month with The Jerusalem Post, Zaks said he moved to the United States because it offered him a greater chance to “fulfill my dream and translate science into medicine.”
“I hope that Israel will continue to develop its bio-tech sector. Wherever I can be most effective is where you’ll find me,” the 54-year-old scientist said.